Chloroacetic Acid

タイトルまたは説明

We are exporting below products: Product, Standard, CAS NO. Packing, etc. Pharmaceutical Intermediates, ((*-methoxybutyl) **-trifluoromethylphenyl) methanone), Formula&#****6;C*3H*5F3O2, Formula weight&#****6;**0, CAS *********7, API, Pharmaceutical Intermediates, (-) Trans*4R (*-fluorophenyl)*3S- hydroxymethyl**-methyl piperidine Enterprise Standard *5kg/ barrel API, Pharmaceutical Intermediates, (-)-Trans*4R-(*-Fluorophenyl)*3S-Hydroxymethyl-N-Methylpiperidine, CAS **********5 API, Pharmaceutical Intermediates, (±)Trans**-(*-fluorophenyl)**-hydroxymethyl**-methyl piperidine Enterprise Standard *5kg/ barrel API, Pharmaceutical Intermediates, (1’R, 2’S, 5’R)-Methyl-(2R, 5S)**-(*-Amino**-Oxo*2H-Pyrimidin**-yl)-[1, 3] Oxathiolane**-Caboxylic acid, CAS **********9 API, Pharmaceutical Intermediates, (1’R, 2’S, 5’R)-Methyl-(2R*5R)-(*-Amino**-Oxo*2H**-Fluoro-Pyrimidin**-yl)-[1, 3] Oxathiolane, CAS **********8 API, Pharmaceutical Intermediates, (1R, 2R)-(+)*1, *-Diphenylethylenediamine API, Pharmaceutical Intermediates, (1S, 2S)-(-)*1, *-Diphenylethylenediamine Pharmaceutical Intermediates, (*-[[[3 methyl**-(2, 2, 2 trifluoroethoxy) *-pyridyl]-methyl] thio]*1H-benzimidazole, CAS **********8, Pharmaceutical Intermediates, (2R,3S/2S,3R)**-(2,*-difluorophenyl)**-(*-fluoropyrimidin**-yl)**-(1H*1,2,*-triazol- *-yl)butan**-ol,CAS No. **********9. FOR Voriconazole Pharmaceutical Intermediates, (2R, 3S/2S, 3R)**-(*-Chloro**-fluoropyrimidin**-yl)**-(2, *-difluorophenyl)**-(1H*1, 2, *-triazol- *-yl)**- butanol hydrochloride, FOR Voriconazole API, Pharmaceutical Intermediates, (2S)-(*-Tetrahydro-Pyrimid**-Only)**-Methyl Botanic Acid, CAS **********1 API, Pharmaceutical Intermediates, (2S, 3R)**-Chloro**-[[(phenylmethoxy) Carbonyl] amino]**-(phenylthio) butan**-ol, CAS **********1 API, Pharmaceutical Intermediates, (2S, 3S, 5S)**-Amino**-Hydroxy*5(T)-Butyloxycarbonylamino*1, *-Diphenyl-Hexane Succinic Acid, CAS **********9 Pharmaceutical Intermediates, (*-Amino**-hydroxypropylidene) bisphosphonic acid, CAS No. *********9 FOR Pamidronate disodium API, Pharmaceutical Intermediates, (3S) N-Tert-Butyl-Decahydro**-Isoquinolinecarboxamide, CAS **********1 Pharmaceutical Intermediates, (*-Amino**-hydroxybutylidene) bisphosphonic acid, CAS No. *********1 FOR Alendronate sodium API, Pharmaceutical Intermediates, (*-Chloropheny) phenyl methylamine *8.0%, Enterprise Standard, *5kg/*0kg API, Pharmaceutical Intermediates, (*-Chloropheny) phenyl methylamine Hydrochloride *8.0%, Enterprise Standard, *5kg/*0kg API, Pharmaceutical Intermediates, (CIS)**-Acetamidocyclopent**-ENE methyl acetate, CAS *********7 Pharmaceutical Intermediates, (R)-(+)**-Carboxy-tetrahydrofuroic-acid Intermediate Pharmaceutical Intermediates, (R)*1, *-butanediol API, Pharmaceutical Intermediates, (R)**-Benzyl**-hrdroxyl-piperidine *7.0% min API, Pharmaceutical Intermediates, (R)**-Benzyl**-hydroxyl-pyridine *7.0% min API, Pharmaceutical Intermediates, (R)**-benzyl**-oxazolidinone, CAS **********7, API, Pharmaceutical Intermediates, (R)**-phenyl**-oxazolidinone, CAS *********1, API, Pharmaceutical Intermediates, (R)-Tetrahydro**-Methyl*1, *-Diphenyl*1H, 3H-Pyrrolo [1, *-c] [1, 3, 2] Oxazoborole, CAS **********0 Pharmaceutical Intermediates, (R)-Trihexyphenidy Pharmaceutical Intermediates, (S)*1, *-Butanediol API, Pharmaceutical Intermediates, (S)**-Amino methyl-N-ethyl pyrrolidine, Uses: Amisulpride Levosulpiride Remoxipride Pharmaceutical Intermediates, (S)**-methoxycyclohexanone Intermediate API, Pharmaceutical Intermediates, (S)**-Hydroxy-&#**7;-Butyrolactone, CAS ********4, API, Pharmaceutical Intermediates, (S)**-benzyl**-oxazolidinone, CAS *********7, API, Pharmaceutical Intermediates, (S)**-phenyl**-oxazolidinone, CAS *********7, API, Pharmaceutical Intermediates, (S)*6, *-Dimethoxy*1, 2, 3, *-tetrahydroisoquindine**-carboxylic tertbutyl ester Enterprise Standard Packing according to need Chemical Intermediate API, Pharmaceutical Intermediates, (S)-Alpha, Alphal-Diphenyl**-Pyrrolidineacetamide, CAS **********3, API, Pharmaceutical Intermediates, (S, S, S)**-Azabicyclo [3, 3, 0]-Octane-Carboxylic Acid Benzyl Ester Hcl, CAS *********2 API,-carotene Pharmaceutical Intermediates, [*-Hydroxy**-(*-pyridinyl) ethylidene] bisphosphonic acid, CAS No. **********6 FOR Risedronate sodium API, Pharmaceutical Intermediates, £¨6, *-dihydro*5H-cyclopnta[b]pyridine) *8.5%, 5kg/*0kg API, Pharmaceutical Intermediates, 1% & *0%&#**6;-Carotene Dry Powder, upon requirements, API, Pharmaceutical Intermediates, *-(2, *-Dichlorophenyl) Perazine. Hydrochloride, CAS *********1 API, Pharmaceutical Intermediates, *-(*-Amino**-Chlorophenyl)*2, 2, *-Trifluoroethanone, CAS **********5 API, Pharmaceutical Intermediates, *-(*-Furoyl) piperazine hydrochloride, USE: Prazosin Terazosin API, Pharmaceutical Intermediates, *-(*-Tetrahydro furoyl) piperazine hydrochloride, Uses: Terazosin API, Pharmaceutical Intermediates, *-(*-chloropropoxy)**-fluoroenzene C9H*0ClFO *8.5% Pharmaceutical Intermediates, 1(3H)-Isobenzofuranone, Phthalide CAS: ******2 API, Pharmaceutical Intermediates, *-(*-Fluorobenzyl)**-chloro-benzimidazole, CAS *********3, an intermediate of mizolastine API, Pharmaceutical Intermediates, *-(*-Fluorophenyl)*1, *-Dihydro-Isobenzofuran**-Carbonitrile, CAS *********1 API, Pharmaceutical Intermediates, *-(*-Bromo**-Methoxyphenyl)-Trycyclo [3.3.1.*3, 7] Decane, CAS **********7 Pharmaceutical Intermediates, 1, (5&#**5;)-Androsten*3, **-diol Pharmaceutical Intermediates, 1, (5&#**5;)-Androsten*3, **-Dione API, Pharmaceutical Intermediates, 1, 2, 3, *-tetrahydroisoquinoline**-carboxylic acid hydrochloride Enterprise Standard Packing according to need Chemical Intermediate API, Pharmaceutical Intermediates, 1, 2, *-Trimethoxybenzene, CAS *******3, an intermediate of pharmaceuticals Pharmaceutical Intermediates, 1, *-benzisothiazol**-one, Formula&#****6;C7H5NOS, Formula weight **1, CAS ********5, Pharmaceutical Intermediates, 1, *-Benzisothiazole, *-(*-piperazinyl), hydrochloride, Formula&#****6;C*1H*4N3S.HCl, Formula weight&#****6;**6.*8, CAS **********6, Pharmaceutical Intermediates, 1, *-cyclohexane Dione, CAS *******9 Pharmaceutical Intermediates, 1, *-diamino benzene, CAS *******2 Pharmaceutical Intermediates, 1, *-Dimethyl**-imidazolidinone (DMI), CAS ******9 API, Pharmaceutical Intermediates, 1, *-Dimethyl-adamantane API, Pharmaceutical Intermediates, 1, *-Benzodioxane**-carboxylic acid, CAS ********7, USE: Doxazosin API, Pharmaceutical Intermediates, 1, *-Dioxane, CAS *******1, API, Pharmaceutical Intermediates, 1, *-Dithiane*2, *-Diol, CAS *********6 API, Pharmaceutical Intermediates, *0, **-Dihydrodibenzo [a, b] cyclohepten **-one; Dibenzosuberone, CAS ********1 Amintriptyline, Noxiptiline API, Pharmaceutical Intermediates, **-nitro-camptothecin API, Pharmaceutical Intermediates, **-Oxo*6.**-hydrodibenzo [b, c] thiepin, CAS ********7, an intermediate of Dothiepin Pharmaceutical Intermediates, ***-Diacetoty**-(acetotymethoty)-propane API, *7a-HYDROXY PROGESTERONE Enterprise Standard API, Pharmaceutical Intermediates, *8?-Glycyrrheti Pharmaceutical Intermediates, **-Nor**-androstenediol Pharmaceutical Intermediates, **-Nor**-androstenedione API, Pharmaceutical Intermediates, *-Acetone-oxo*3, *-difluoro-nitrobenzene API, Pharmaceutical Intermediates, *-Adamantanol API, Pharmaceutical Intermediates, *-Adamantyl Methyl Ketone API, Pharmaceutical Intermediates, *-Admantane Carboxylic Acid Pharmaceutical Intermediates, *-Aminohydantoin, *-Amino*2, *-imidazolinedione Pharmaceutical Intermediates, *-Benzoyl*1, *-Dihydro quinoldonitrile API, Pharmaceutical Intermediates, *-Benzoyl**-ethyl**-phenyl barbitoric acid, CAS *******9, API, Pharmaceutical Intermediates, *-Bromo*2, *-difluorobenzene C6H3F2Br *9% API, Pharmaceutical Intermediates, *-bromo**-fluorobenzene C6H4BrF *9% API, Pharmaceutical Intermediates, *-Bromo*3, *-dimethyladamantane API, Pharmaceutical Intermediates, *-bromo**-fluorobenzene C6H4BrF *9% API, Pharmaceutical Intermediates, *-Bromoadamantane API, Pharmaceutical Intermediates, *-Chloro**-(1, *-dimethyl ethyl) benzene ether, CAS ********3, a intermediate of chem API, Pharmaceutical Intermediates, *-Cyclopropyl*6, *-difluoro*1, *-dihydro**-methoxy**-oxo**-quinoline carboxylic acid ethyl ester, USE: Gatifloxacin Moxifloxacin Pharmaceutical Intermediates, *-ethyl**-(dimethylaminopropyl) carbodiimidehydrochloride Intermediate Pharmaceutical Intermediates, 1H-benzotriazol, CAS ******7 API, Pharmaceutical Intermediates, *-Hydroxy Benzotriazole API, Pharmaceutical Intermediates, *-Phenylpiperazine *8.0%, Enterprise Standard; *5kg/*0kg Pharmaceutical Intermediates, *-Testosterone Pharmaceutical Intermediates, *-(*-Adamantyl)**-bromo-anisole, FOR Adapalene Pharmaceutical Intermediates, *-(1H-imidazol**-yl) acetic acid hydrochloride, FOR Zoledronic acid API, Pharmaceutical Intermediates, *-(*-Ethoxyphenoxy) Bromide Ethane, CAS ********8 Pharmaceutical Intermediates, *-(*-methoxyphenoxy) ethyl**-methylbenzensulfonate, CAS **********7 API, Pharmaceutical Intermediates, *-(*-methoxyphenoxy) ethylamine CAS No.********0 *8.5% min API, Pharmaceutical Intermediates, *-(*-methoxyphenoxy) ethylamine hydrochloride CAS No. [*********9] *9.0% min Pharmaceutical Intermediates, *-(*-pyridinyl) acetic acid hydrochloride, FOR Risedronate sodium API, Pharmaceutical Intermediates, *-(*-Chloro phenoxy) tert butane, CAS *********2, Pharmaceutical Intermediates, *-(*-Chlorophenoxy) ethyl chloride, CAS ******2, API, Pharmaceutical Intermediates, *-(Bromo methyl) tetra hydrofuran, CAS ********9, electronic chemical API, Pharmaceutical Intermediates, *-(Ethyl amino) ethanol Enterprise Standard **0Kg/ barrel Chemical Intermediate API, Pharmaceutical Intermediates, *-(Trifluoroethoxy)aniline Assay:*9%MIN, CAS ********7 API, Pharmaceutical Intermediates, *-(trifluoroethoxy) bromobenzene Assay: *9%MIN, CAS *********4 API, Pharmaceutical Intermediates, *-(Trifluoromethyl) thioxanthen**-one, CAS ********3, USE: Flupentixol Pharmaceutical Intermediates, 2, *-Dimethoxy*4 –Methylphenol CAS: ********7 API, Pharmaceutical Intermediates, 2, *-Dimethylbutyvic Acid *8% Pharmaceutical Intermediates, 2, 2’-Dithiosalicy acid, CAS *******2 API, Pharmaceutical Intermediates, 2, 3, *-Trifluorobenzoic acid C7H3F3O2 *8% Pharmaceutical Intermediates, 2, 3, *-trifluoronitrobenzene, CAS *******7 Pharmaceutical Intermediates, 2, 3, *-trifluoronitrobenzene, CAS *******7 Pharmaceutical Intermediates, 2, 3, *-Trihydroxybenzaldehyde Pharmaceutical Intermediates, 2, 3, *-Trihydroxybenzaldehyde, CAS *********3 Pharmaceutical Intermediates, 2, *-Acid: Used for dyes, pigments, intermediates of pharmaceutical. API, Pharmaceutical Intermediates, 2, *-cyclopentenopyridine *8.0%, Enterprise Standard, 1kg/5kg API, Pharmaceutical Intermediates, 2, *-Dibromopropionyl chloride, CAS *********1, an intermediate of dyestuff Pharmaceutical Intermediates, 2, *-Dichloro*5, *-dicyano*1, *-benzoquinone API, Pharmaceutical Intermediates, 2, *-Dichloro*5, *-dicyanobenzoquinone, CAS ******2 API, Pharmaceutical Intermediates, 2, *-Dichloro**-Nitro-benzonitrile, CAS ********3 API, Pharmaceutical Intermediates, 2, *-Difluoro**-nitrophenol C6H3F2NO3 *8.5% Pharmaceutical Intermediates, 2, *-dihydro*2, *-dimethyl**-hydroxy benzofurane API, Pharmaceutical Intermediates, 2, *-Dihydrofuran, CAS ********7, an intermediate of etodolac API, Pharmaceutical Intermediates, 2, *-dimethyl**-nitropyridine-N-oxide, CAS *********7 light yellow powder, Purity&#***5;*9.5 Pharmaceutical Intermediates, 2, *-dimethyl**-nitro-pyridine-N-oxide &#***5;*9.0% Drug intermediate *0kg/pail Pharmaceutical Intermediates, 2, *-trimethylene pyridine Intermediate Pharmaceutical Intermediates, 2, *- dichloride phenyl: Pesticide and Pharmaceutical intermediates Pharmaceutical Intermediates, 2', 4", *-O-tris (benzyl)-erythromycin A**-oxime Intermediate Pharmaceutical Intermediates, 2, 4, *-Trichlorophenol, CAS ******4, Pharmaceutical Intermediates, 2, 4, *-Tribromophenol, CAS *******6, Pharmaceutical Intermediates, 2, 4, *-Trichlorophenol, CAS ******2, Pharmaceutical Intermediates, 2, 4, *-Trihydroxyacetophenone, CAS *******0 Pharmaceutical Intermediates, 2, *-Dichloro*5aminophenol, Pharmaceutical Intermediates, 2, *-dichloro-benzoic acid, CAS ******0 Pharmaceutical Intermediates, 2, *-Dichlorophenol, CAS *******2, API, Pharmaceutical Intermediates, 2, *-Difluoroaniline Assay: *9%MIN, CAS *******9 API, Pharmaceutical Intermediates, 2, *-difluoroaniline C6H5F2N *9% API, Pharmaceutical Intermediates, 2, *-Difluorobenzonitrile C7H3F2N *9% API, Pharmaceutical Intermediates, 2, *-difluoronirobenzene C6H3F2NO2 *9% API, Pharmaceutical Intermediates, 2, *-Difluorophenol C6H4F2O *8% API, Pharmaceutical Intermediates, 2, *-Dihydro**-[[*-(*-hydroxyphenyl)**-piperazinyl]-phenyl]**- (*-methyl propyl)*3H*1, 2, *-triazol**-one, CAS *********5, USE: Itraconazole Pharmaceutical Intermediates, 2, *-Dihydroxyacetophenone, CAS ******9 API, Pharmaceutical Intermediates, 2, *-Dihydroxy benzoic acid, CAS *******9, USE: Flecainide API, Pharmaceutical Intermediates, 2, *-Dimethyl phenol, CAS ******4, USE: Gemfibrozil Pharmaceutical Intermediates, 2, *-Dichloro*4aminophenol, Pharmaceutical Intermediates, 2, *-dichlorobenzaldehyde, CAS ******5 Pharmaceutical Intermediates, 2, *-dichloronicotinic acid, CAS *********3 white or almost white powder, Purity &#***5;*9.0 API, Pharmaceutical Intermediates, 2, *-Dichlorophenol, CAS ******0, Pharmaceutical Intermediates, 2, *-Dichloropurine *7.0~**2.0% Antineoplastic, antivirus drug intermediate API, Pharmaceutical Intermediates, 2, *-Dichloropurine Assay: *9%MIN, CAS ********1 API, Pharmaceutical Intermediates, 2, *-difluoroaniline C6H5F2N *9% API, Pharmaceutical Intermediates, 2, *-difluorobenzoic acid C7H4F2O2 *9% Pharmaceutical Intermediates, 2, *-Dihydroxyacetophenone, CAS *******2 API, Pharmaceutical Intermediates, 2, *-Dimethyl Phenol, CAS *******1 Pharmaceutical Intermediates, 2, *-dimethyl*3H-quinazolin**-one, Formula&#****6;C*0H*0N2O, Formula weight&#****6;**4, CAS *********6, API, Pharmaceutical Intermediates, 2, *-dimethyl**-(*-nitrophenyl)*1, *-dihydrpyridine****-dimethoxycarboxyl *7.0% min API, Pharmaceutical Intermediates, 2, *-Di-tert-butylnaphthalene&#***5;*8%, C*8H*4, CAS ********4 API, Pharmaceutical Intermediates, *-[*-(Bromomethyl) phenyl] Prop ionic Acid, CAS **********2 API, Pharmaceutical Intermediates, ***-Nitroso**-Naphthol *8% API, Pharmaceutical Intermediates, *-Adamantanone Pharmaceutical Intermediates, *-amino*3, *-dinitro thiophene, CAS ********7 Pharmaceutical Intermediates, *-Amino**-methyl pyridine API, Pharmaceutical Intermediates, *-Amino*4, *-Dichloro Pyrimidine, CAS ******3 Pharmaceutical Intermediates, *-amino**-thiazole acetic acid, Formula&#****6;C5H6N2O2S, Formula weight&#****6;**8, CAS *********9, API, Pharmaceutical Intermediates, *-Amino**-bromo**-chloro benzophenone, USE: Phenazpam API, Pharmaceutical Intermediates, *-Amino**-Chloro benzonitrile, CAS ********1, an intermediate of intermediate API, Pharmaceutical Intermediates, *-Amino**-methyl thiazole, CAS ********7, USE: Meloxicam Pharmaceutical Intermediates, *-Amino**-chloropurine *8.0 ~ **2.0% Antiviral drugs, Famciclovir intermediate Cardboard drum, *5kg/pail Pharmaceutical Intermediates, *-Amino**-iodopurine &#***5;*7.0% Drug intermediate Cardboard drum, *5kg/pail Pharmaceutical Intermediates, *-Amino**-methoxypurine &#***5;*8.0% Drug intermediate on the requirements API, Pharmaceutical Intermediates, *-Aminomethyl*3, *-Dichloro-Phenylamine, CAS **********1 API, Pharmaceutical Intermediates, *-Azabicyclo [2, 2, 1] Heptan**-ene**-One, CAS *********3 API, Pharmaceutical Intermediates, *-Azabicyclo [3, 3, 0]-Octane-Carboxylic Acid benzyl ester hydroxychloride, CAS *********4 Pharmaceutical Intermediates, *-Benzyl-acrylic acid, CAS *********1, API, Pharmaceutical Intermediates, *-Bromo**-Fluorobenzoic acid Assay: *9%MIN, CAS ********3 API, Pharmaceutical Intermediates, *-Bromo**-Fluorotoluene Assay: *9%MIN, CAS ********3 API, Pharmaceutical Intermediates, *-Bromo**-Fluorobenzoic acid Assay: *9%MIN, CAS *******5 API, Pharmaceutical Intermediates, *-Bromo**-Fluorotoluene Assay: *9%MIN, CAS *******1 API, Pharmaceutical Intermediates, *-Bromo**-Methoxy Naphthalene, CAS ********9, an intermediate of nabumeton API, Pharmaceutical Intermediates, *-Bromo**-methoxy Naphthalene, CAS ********9, USE: Nabumeton API, Pharmaceutical Intermediates, *-Bromobenzotrifluoride Assay: *9%MIN, CAS *******6 API, Pharmaceutical Intermediates, *-Chloro acetamido*2', *-dichloro benzophenone, CAS *********9, USE: Lorazepam Triazolam API, Pharmaceutical Intermediates, *-Chloro benzimidazole, CAS ********1, an intermediate of mizolastine API, Pharmaceutical Intermediates, *-Chloro**0, **-Dihydro***-oxo-Dibenz [b, c] [1, 4] oxazepine, Quality Standard *9%, CAS ********6 Pharmaceutical Intermediates, *-Chloro*3, *-dimethoxybenzaldehyde, Formula&#****6;C9H9ClO3, Formula weight&#****6;**0.5, CAS ********4, API, Pharmaceutical Intermediates, *-Chloro*3, *-dimethyl**-methoxy pyidine, USE: Omeprazole API, Pharmaceutical Intermediates, *-Chloro**-Amino**-Isobutyl Amino Quinoline, CAS **********1 API, Pharmaceutical Intermediates, *-Chloro**-Amino**-Methyl Pyridine, CAS **********6 Pharmaceutical Intermediates, *-Chloro**-nitropyridine API, Pharmaceutical Intermediates, *-Chloro*4, *-difluorobenzoic acid C7H3ClF2O2 *8.5% API, Pharmaceutical Intermediates, *-Chloro**-amino*6, *-dimethoxy-quinazoline, CAS *********4, an intermediate of doxazosin esylate API, Pharmaceutical Intermediates, *-chloro**-cyanopyridine, CAS *********1 white or light yellow powder, Purity &#***5;*9.0 API, Pharmaceutical Intermediates, *-Chloro**-fluorophenol C6H4ClFO *8.5% API, Pharmaceutical Intermediates, *-Chloroisonicotinic acid, CAS ********8 white or almost white powder, Purity&#***5;*9.0 Pharmaceutical Intermediates, *-chloromethyl*3, *-dimethyl**-dimethoxypyridinium hydrochloride &#***5;*9.5% *0, *0 kg/pail API, Pharmaceutical Intermediates, *-Chloro-N-(*-Chloro**-Methyl**-Pyridinly)**-Pyridinecarboxamide, CAS **********0 API, Pharmaceutical Intermediates, *-Chlorothioxanthen**-one, CAS [******5], USE: Chlorprothixene Zuclopenthixol Pharmaceutical Intermediates, *-Chlorotoluene, content&#***5;*9.5% API, Pharmaceutical Intermediates, *-Cyano pyrazine, CAS *********2, USE: Pyrazinamide API, Pharmaceutical Intermediates, *-Cyano*4'-methyl biphenyl, CAS [**********1], USE: Losartan Irbesartan Candesartan Valsartan Pharmaceutical Intermediates, *-Ethoxy carbonyl Methoxy**-(*-Methyl**-butenyloxy) acetophenone, CAS *********3 API, Pharmaceutical Intermediates, *-Ethoxy**-[[2’-(*-Triphenylmethyl)*2H-Tetrazole**-Yl] (1, 1’-Biphenyl)**-Yl]-Methyl] Benzimidazole**-Carboylic acid, CAS **********4 API, Pharmaceutical Intermediates, *-Ethyl phenyl hydrazine hydrochloride, CAS *********7, an intermediate of etodolac API, Pharmaceutical Intermediates, *-Ethylphenyl hydrazine hydrochloride, AS [*********7], USE: Etodolac API, Pharmaceutical Intermediates, *-fluoranisole C7H7FO *9% API, Pharmaceutical Intermediates, *-Fluoro*2',3',5'-tri-o-acetyladenosine Enterprise Standard Packing according to need Fludarabine Intermediate API, Pharmaceutical Intermediates, *-Fluoro**-nitroaniline C6H5FN2O2 *9% Pharmaceutical Intermediates, *-fluoro**-chloropurine &#***5;*8.0% Drug intermediate on the requirements API, Pharmaceutical Intermediates, *-Fluoroacetanilide C8H8FNO *9% API, Pharmaceutical Intermediates, *-Fluoroadenosine Enterprise Standard Packing according to need Fludarabine Intermediate API, Pharmaceutical Intermediates, *-Fluorobenzoic acid Assay: *9%MIN, CAS *******4 API, Pharmaceutical Intermediates, *-Fluorobenzonitrile C7H4FN *9% API, Pharmaceutical Intermediates, *-Fluoropheny hydrazine C6H7FN2 *8% API, Pharmaceutical Intermediates, *-Hydroxy**-Naphthaldehyde *8% API, Pharmaceutical Intermediates, *-Hydroxy**-quinolincarboxylic acid *8.0%, Enterprise Standard; *5kg/*0kg API, Pharmaceutical Intermediates, *-Hydroxynicotinic acid, CAS *******2 white or almost white powder, Purity&#***5;*9.0 API, Pharmaceutical Intermediates, *-hydroxyquinoline**-formylchloride *8.0%, Enterprise Standard; *0kg/*0kg Pharmaceutical Intermediates, *-hydroxyquinoxaline API, Pharmaceutical Intermediates, *-imidazolealdehyde Pharmaceutical Intermediates, *-imidazolidinone, CAS *******4 API, Pharmaceutical Intermediates, *-Iodoethanol *8% API, Pharmaceutical Intermediates, *-Isopropyl**-(Methylaminomethyl) Thiazole, CAS **********9 API, Pharmaceutical Intermediates, *-Mercapto benzimidazole, CAS *******1, an intermediate of pharmaceuticals Pharmaceutical Intermediates, *-Mercaptopyridine *8% min CAS ********5 API, Pharmaceutical Intermediates, *-Methoxycarbonylmethoxy**-(*-Methyl**-Butenyloxy) Acetophenone, CAS, CAS *********4 API, Pharmaceutical Intermediates, *-Methyl indoline, CAS [********6], USE: Indapamide API, Pharmaceutical Intermediates, *-Methyl piperazine, CAS [*******9], USE: Ofloxacin Levofloxacin Pharmaceutical Intermediates, *-Methyl quinoline, content&#***5;*9.5% API, Pharmaceutical Intermediates, *-Methyl**-hydroxy*2H*1.*-benzothiazine**-carboxylic acid ethyl ester*1.*-dioxide, CAS [*********9], USE: Meloxicam Piroxicam API, Pharmaceutical Intermediates, 2'-Methylacetophenone, CAS *******2, API, Pharmaceutical Intermediates, *-Methylthio**-pyrimidone, CAS ********2, an intermediate of mizolastine API, Pharmaceutical Intermediates, *-nitro**-hydroxybenzaldehycle Pharmaceutical Intermediates, *-Nitro**-Hydroxybenzaldehyde API, Pharmaceutical Intermediates, *-Phenylmethylthionicotinic acid, CAS **********2, Purity &#***5;*8.0 API, Pharmaceutical Intermediates, *-pyridylacetic acid hydrochloride CAS No: [*********8].